Glioma stem cells targeted by oncolytic virus carrying endostatin- angiostatin fusion gene and the expression of its exogenous gene in vitro

Brain Research

Volumn 1390, Issue , 2011, Pages 59-69

  Zhu, Guidong ^a   Su, Wei ^a   Jin, Guishan ^a   Xu, Fujian ^b   Hao, Shuyu ^a   Guan, Fangxia ^c   Jia, William ^d   Liu, Fusheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

^c ZHENGZHOU UNIVERSITY   (China)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Brain glioma; Endostatin angiostatin; Glioma stem cells; Virus gene therapy

Indexed keywords

CD133 ANTIGEN; ENDOSTATINS ANGIOSTATIS FUSION PROTEIN; HYBRID PROTEIN; NESTIN; ONCOLYTIC VIRUS; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GENE THERAPY; CANCER INHIBITION; CANCER STEM CELL; CANCER TISSUE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; FUSION GENE; GENE EXPRESSION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MOLECULARLY TARGETED THERAPY; NERVE CELL CULTURE; NEURAL STEM CELL; ONCOLYTIC VIROTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL DESTRUCTION; VASCULAR ENDOTHELIUM;

ANGIOSTATINS; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; ENDOSTATINS; GENE THERAPY; GLIOMA; HUMANS; NEOPLASTIC STEM CELLS; ONCOGENE PROTEINS, FUSION; ONCOLYTIC VIRUSES; RATS; TUMOR CELLS, CULTURED;

EID: 79955634782     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.03.050     Document Type: Article

References (36)

1. Aghi, M., Martuza, R.L., 2005. Oncolytic viral therapies - the clinical experience. Oncogene 24, 7802-7816. (Pubitemid 41670681)
2. Bao, S., Wu, Q., Sathornsumetee, S., Hao, Y., Li, Z., Hjelmeland, A.B., Shi, Q., McLendon, R.E., Bigner, D.D., Rich, J.N., 2006. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res. 66, 7843-7848. (Pubitemid 44299144)
3. Bonnet, D., Dick, J.E., 1997. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730-737.
4. Calabrese, C., Poppleton, H., Kocak, M., Hogg, T.L., Fuller, C., Hamner, B., Oh, E.Y., Gaber, M.W., Finklestein, D., Allen, M., Frank, A., Bayazitov, I.T., Zakharenko, S.S., Gajjar, A., Davidoff, A., Gilbertson, R.J., 2007. A perivascular niche for brain tumor stem cells. Cancer Cell 11, 69-82. (Pubitemid 46054518)
5. Cho, D.Y., Lin, S.Z., Yang, W.K., Hsu, D.M., Lin, H.L., Lee, H.C., Lee, W.Y., Chiu, S.C., 2010. The role of cancer stem cells (CD133+) in malignant gliomas. Cell Transplant.
6. Chou, J., Kern, E.R., Whitley, R.J., Roizman, B., 1990. Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science 250, 1262-1266. (Pubitemid 120031840)
7. De Bouard, S., Guillamo, J.S., Christov, C., Lefevre, N., Brugieres, P., Gola, E., Devanz, P., Indraccolo, S., Peschanski, M., 2003. Antiangiogenic therapy against experimental glioblastoma using genetically engineered cells producing interferon-alpha, angiostatin, or endostatin. Hum. Gene Ther. 14, 883-895.
8. Dey, M., Ulasov, I.V., Lesniak, M.S., 2010. Virotherapy against malignant glioma stem cells. Cancer Lett. 289, 1-10.
9. Dhanabal, M., Ramchandran, R., Waterman, M.J., Lu, H., Knebelmann, B., Segal, M., Sukhatme, V.P., 1999. Endostatin induces endothelial cell apoptosis. J. Biol. Chem. 274, 11721-11726.
10. Ferrara, N., Kerbel, R.S., 2005. Angiogenesis as a therapeutic target. Nature 438, 967-974. (Pubitemid 43093963)
11. Folkman, J., 1990. What is the evidence that tumors are angiogenesis dependent? J. Natl Cancer Inst. 82, 4-6. (Pubitemid 20020880)
12. Folkman, J., 1995. Angiogenesis inhibitors generated by tumors. Mol. Med. 1, 120-122.
13. Gilbertson, R.J., Rich, J.N., 2007.Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat. Rev. Cancer 7, 733-736.
14. Hoffmann, D., Wildner, O., 2007. Comparison of herpes simplex virus- and conditionally replicative adenovirus-based vectors for glioblastoma treatment. Cancer Gene Ther. 14, 627-639. (Pubitemid 46912039)
15. Jensen, R.L., 2009. Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. J. Neurooncol. 92, 317-335.
16. Kassem, N.M., 2008. Review article: cancer stem cells: from identification to eradication. J. Egypt Natl. Canc. Inst. 20, 209-215.
17. Kiel, M.J., Morrison, S.J., 2008. Uncertainty in the niches that maintain haematopoietic stem cells. Nat. Rev. Immunol. 8, 290-301.
18. Liu, T.C., Galanis, E., Kirn, D., 2007. Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress. Nat. Clin. Pract. Oncol. 4, 101-117.
19. Manservigi, R., Argnani, R., Marconi, P., 2010. HSV recombinant vectors for gene therapy. Open Virol. J. 4, 123-156.
20. Moore, K.A., Lemischka, I.R., 2006. Stem cells and their niches. Science 311, 1880-1885.
21. Moser, T.L., Stack, M.S., Asplin, I., Enghild, J.J., Hojrup, P., Everitt, L., Hubchak, S., Schnaper, H.W., Pizzo, S.V., 1999. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc. Natl Acad. Sci. U.S.A. 96, 2811-2816.
22. Nguyen, T.M., Subramanian, I.V., Xiao, X., Ghosh, G., Nguyen, P., Kelekar, A., Ramakrishnan, S., 2009. Endostatin induces autophagy in endothelial cells by modulating Beclin 1 and beta-catenin levels. J. Cell. Mol. Med. 13, 3687-3698.
23. Parato, K.A., Senger, D., Forsyth, P.A., Bell, J.C., 2005. Recent progress in the battle between oncolytic viruses and tumours. Nat. Rev. Cancer 5, 965-976.
24. Pinto, A., Redondo, A., Zamora, P., Castelo, B., Espinosa, E., 2010. Angiogenesis as a therapeutic target in urothelial carcinoma. Anticancer Drugs 21, 890-896.
25. Schmidt, N.O., Koeder, D., Messing, M., Mueller, F.J., Aboody, K.S., Kim, S.U., Black, P.M., Carroll, R.S., Westphal, M., Lamszus, K., 2009. Vascular endothelial growth factor-stimulated cerebral microvascular endothelial cells mediate the recruitment of neural stem cells to the neurovascular niche. Brain Res. 1268, 24-37.
26. Selznick, L.A., Shamji, M.F., Fecci, P., Gromeier, M., Friedman, A.H., Sampson, J., 2008. Molecular strategies for the treatment of malignant glioma-genes, viruses, and vaccines. Neurosurg. Rev. 31, 141-155 discussion 155.
27. Shen, Q., Goderie, S.K., Jin, L., Karanth, N., Sun, Y., Abramova, N., Vincent, P., Pumiglia, K., Temple, S., 2004. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304, 1338-1340. (Pubitemid 38697433)
28. Silva, J., Nichols, J., Theunissen, T.W., Guo, G., van Oosten, A.L., Barrandon, O., Wray, J., Yamanaka, S., Chambers, I., Smith, A., 2009. Nanog is the gateway to the pluripotent ground state. Cell 138, 722-737.
29. Singh, S.K., Hawkins, C., Clarke, I.D., Squire, J.A., Bayani, J., Hide, T., Henkelman, R.M., Cusimano, M.D., Dirks, P.B., 2004. Identification of human brain tumour initiating cells. Nature 432, 396-401. (Pubitemid 39551674)
30. Stupp, R., Mason, W.P., van den Bent, M.J., Weller, M., Fisher, B., Taphoorn, M.J., Belanger, K., Brandes, A.A., Marosi, C., Bogdahn, U., Curschmann, J., Janzer, R.C., Ludwin, S.K., Gorlia, T., Allgeier, A., Lacombe, D., Cairncross, J.G., Eisenhauer, E., Mirimanoff, R.O., 2005. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987-996.
31. Takakura, N., 2010. Visualization of cancer stem cells and their vascular niche. Rinsho Ketsueki 51, 632-637.
32. Thurnher, M.M., 2009. 2007 World Health Organization classification of tumours of the central nervous system. Cancer Imaging 9 Spec No A, S1-S3.
33. Todo, T., 2008. Oncolytic virus therapy using genetically engineered herpes simplex viruses. Front. Biosci. 13, 2060-2064.
34. Wakimoto, H., Kesari, S., Farrell, C.J., Curry, W.J., Zaupa, C., Aghi, M., Kuroda, T., Stemmer-Rachamimov, A., Shah, K., Liu, T.C., Jeyaretna, D.S., Debasitis, J., Pruszak, J., Martuza, R.L., Rabkin, S.D., 2009. Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. Cancer Res. 69, 3472-3481.
35. Wulf, G.G., Wang, R.Y., Kuehnle, I., Weidner, D., Marini, F., Brenner, M.K., Andreeff, M., Goodell, M.A., 2001. A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. Blood 98, 1166-1173.
36. Yokoyama, Y., Dhanabal, M., Griffioen, A.W., Sukhatme, V.P., Ramakrishnan, S., 2000. Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth. Cancer Res. 60, 2190-2196. (Pubitemid 30225182)